Surfactant Suppresses NF-κB Activation in Human Monocytic Cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 4, 1996, Pages 374-379

  Antal, Joyce M ^a   Divis, Lisa T ^a   Erzurum, Serpil C ^a   Wiedemann, Herbert P ^a   Thomassen, Mary Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LUNG SURFACTANT; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MONOCYTE; NUCLEOTIDE SEQUENCE; SECRETION;

BASE SEQUENCE; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MONOCYTES; NF-KAPPA B; PULMONARY SURFACTANTS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030118203     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.4.8600942     Document Type: Article

References (29)

1. Caminiti, S. P. and S. L. Young. 1991. The pulmonary surfactant system. Hosp. Pract. 87-100.
2. Roth, M. D., M. Pinto, S. H. Golub, and H. Shau. 1993. Pulmonary surfactant inhibits interleukin-2-induced proliferation and the generation of lymphokine-activated killer cells. Am. J. Respir. Cell Mol. Biol. 9: 652-658.
3. Woerndle, S., and P. Bartmann. 1994. The effect of three surfactant preparations on in vitro lymphocyte functions. J. Perinat. Med. 22:119-128.
4. Thomassen, M. J., D. P. Meeker, J. M. Antal, M. J. Connors, and H. P. Wiedemann. 1992. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 7:257-260.
5. Thomassen, M. J., J. M. Antal, M. J. Connors, D. P. Meeker, and H. P. Wiedemann. 1994. Characterization of Exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophages cytokine responses. Am. J. Respir. Cell Mol. Biol. 10:399-404.
6. Trede, N. F., E. Castigli, R. S. Geha, and T. Chatila. 1993. Microbial superantigens induce NF-κB in the human monocytic cell line THP-1. J. Immunol. 150:5604-5613.
7. Geertsma, M. F., W. L. Teeuw, P. H. Nibbering, and R. van Furth. 1994. Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma. Immunology 82:450-456.
8. Speer, C. P., B. Gotze, T. Curtstedt, and B. Robertson. 1991. Phagocytic functions and tumor necrosis factor secretion of human monocytes to natural porcine surfactant (Curosurf). Pediatr. Res. 30:69-74.
9. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
10. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Ann. Rev. Immunol. 12:141-179.
11. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
12. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, New York.
13. Thomassen, M. J., M. Ahmad, B. P. Barna, J. Antal, H. P. Wiedemann, D. P. Meeker, J. Klein, L. Bauer, V. Gibson, S. Andresen, and R. M. Bukowski. 1991. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony stimulating factor therapy. Cancer Res. 51:857-862.
14. Dent, C. L., and D. S. Latchman. 1993. The DNA mobility shift assay. In Transcription Factors. D. S. Latchman, editor. Oxford University Press, New York. 1-26.
15. Ghio, A. J., P. J. Fracica, S. L. Young, and C. A. Piantadosi. 1994. Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. J. Appl. Physiol. 77:1217-1223.
16. Huang, Y. T., A. C. Sane, S. G. Simonson, T. A. Fawcett, R. E. Moon, P. J. Fracica, M. G. Menache, C. A. Piantadosi, and S. L. Young. 1995. Artificial surfactant attentuates hyperoxic lung injury in primates. I. Physiology and biochemistry. J. Appl. Physiol. 78:1816-1822.
17. Kremlev, S. G., T. M. Umstead, and D. S. Phelps. 1994. Effect of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J. Physiol.: Lung Cell. Mol. Physiol. 267:L357-364.
18. Kremlev, S. G., and D. S. Phelps. 1994. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am. J. Physiol.: Lung Cell. Mol. Physiol. 267:L712-719.
19. Weissbach, S., A. Neuendank, M. Petterson, T. Schaber, and U. Pison. 1994. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. Am. J. Physiol.: Lung Cell. Mol. Physiol. 267:L660-666.
20. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
21. Hallman, M., R. Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure. J. Clin. Invest. 70:673-683.
22. Pison, U., U. Obertacke, M. Brand, W. Seeger, T. Joka, J. Bruch, and K. P. Schmit-Neuerburg. 1990. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of adult respiratory failure. J. Trauma 30:19-26.
23. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K. Schmit-Neuerburg. 1989. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140:1033-1039.
24. Hyers, T. M., S. M. Tricomi, P. A, Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
25. Jacobs, R. F., D. R. Tabor, A. W. Burks, and G. D. Campbell. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 140:1686-1692.
26. Kelly, J. Cytokines of the lung. 1990. Am. Rev. Respir. Dis. 141:765-788.
27. Tracey, K. J., S. F. Lowry, and A. Cerami. 1988. Cachectin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:1377-1379.
28. Marks, J. D., C. B. Marks, J. M. Luce, A. B. Montgomery, J. Turner, C. A. Metz, and J. F. Murray. 1990. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141:94-97.
29. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hairir, T. J. Fahey, III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.